who makes bpc 157 BPC-157 Explained: Benefits, Safety & Oral vs Injectable Options BPC-157 - Research-Grade Peptide |

As of 2026, no registered Phase I or Phase II trials for KPV in humans are listed on ClinicalTrials.gov.12 The FDA specifically cited the lack of human exposure data as part of its 2023 categorization decision.8 What this means practically: Efficacy signals from animal models do not automatically translate to human outcomes Long-term safety in human populations has not been established Dosing protocols remain clinical judgment calls rather than evidence-based standards Any patient considering KPV should do so under clinical supervision with baseline inflammatory marker testing These limitations do not invalidate the research

Always follow the laws and institutional rules that apply to handling research compounds.

Novel drugs approved by the EMA, the FDA and the MHRA in 2025

We ensure our patients are informed about the potential side effects of any treatment

It is used in laboratory settings to reconstitute peptides and other research compounds

Published Date: At Fountain of Youth Medical Spa in Victoria, TX, Dr